Darmstadt
Merck Investing $70M In Biopharm R&D Facility Expansion
The German company, which operates its biopharm business as EMD Serono in the U.S. and Canada, will invest $70 million to expand its Billerica, MA facility.
Merck Opens New Pharma Packaging Center In Germany
The $73 million investment is part of wider $1 billion investment that will transform the Darmstadt site into the company’s contemporary global headquarters.